title: A new management approach for dental treatment after a cerebrovascular event: a comparative retrospective study.
abstract: OBJECTIVE
  Current literature recommends postponing dental treatment until 6-12 months after a stroke, based on the presumed risk of recurrent stroke. The purpose of this study was to suggest that the importance of dental care during this period exceeds the risk of medical complications in this patient population.
  
  
  METHODS
  Two groups were compared: 1) a cerebrovascular (CrbV) study group: patients (n = 16) who had suffered from a CrbV event within the 12 months preceding their dental procedure; and 2) a cardiovascular (CV) control group: patients (n = 25) suffering from ischemic CV disease. Patients were monitored during and after the dental treatment. Treatment parameters and outcome were compared.
  
  
  RESULTS
  Patients received various essential dental treatments with intense monitoring during their dental management. Dental procedures were invasive in 68.8% and 0% of CrbV and CV groups, respectively. Dental treatments were completed uneventfully. No clinical CrbV or CV complications were noted in either group after the dental treatment.
  
  
  CONCLUSIONS
  Within the limits of this small retrospective study, it appears that dental treatment may be safely administered in patients a few weeks after the CrbV event as long as these patients are kept under optimal medical surveillance.
authors.affiliation: Department of Oral Medicine, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel. eladhome@md.huji.ac.il
authors.forename: Sharon
authors.initials: S
authors.lastname: Elad
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Zadik
authors.forename: Eliezer
authors.initials: E
authors.lastname: Kaufman
authors.forename: Ronen
authors.initials: R
authors.lastname: Leker
authors.forename: Ori
authors.initials: O
authors.lastname: Finfter
authors.forename: Mordechai
authors.initials: M
authors.lastname: Findler
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002318:Cardiovascular Diseases; D016022:Case-Control Studies; D017742:Dental Care for Chronically Ill; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012189:Retrospective Studies; D018570:Risk Assessment; D018709:Statistics, Nonparametric; D013315:Stress, Psychological / Q000517:prevention & control; D020521:Stroke
chemical_list: D000925:Anticoagulants; D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors